Osteopathic Manipulative Treatment and Migraine Headaches
Chronic Migraine, Migraine Disorders, Headache Disorders
About this trial
This is an interventional treatment trial for Chronic Migraine focused on measuring OMT, Osteopathic Manipulative Therapy, Migraine, Headache
Eligibility Criteria
Inclusion Criteria:
- Age: 18-50
- Gender: Male and Female
- ICD 10 code of migraine with or without aura (G43.0, G43.1, G43.70, G43.71)
- No change in prophylactic medication for both control and intervention group
- No physical therapy for headaches, neck pain or for trapezius muscle during 12 weeks for both control and intervention group
Exclusion Criteria:
- Previous Surgery to neck or cranium, history of previous stroke
- More than two daily prophylactic pharmacologic agents used for the indication of Migraine headache
- Active cancer
- Receiving BOTOX® for migraines or treatment within the last 4 months
- If patient has contraindications for OMT for the intervention group such as clinical signs of fractures in cervical spine, ligament instability, or severe vertebral artery stenosis
- If patient is poor candidate for OMT in intervention group such as the patient is unable to follow commands.
- Seizure disorder or recent head trauma
- Pregnant or become pregnant during the treatment period
Sites / Locations
- St. Luke's University Health Network
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Interventional Group receiving Osteopathic Manipulative Therapy (OMT)
Control Group with Standard of Care
70 patients with chronic migraine who consent to OMT will receive four standardized osteopathic manipulative treatment protocol over the course of twelve weeks at week 0,2,6,10. MIDAS and HIT-6 Questionnaires will be obtained at time of consent prior to first treatment and again at the conclusion of treatment period of twelve weeks.
70 patients with the diagnosis of migraine headache who are receiving the standard of care medications will complete a MIDAS and HIT-6 questionnaire at week 0 and week 12. A new prophylactic medication may be started at time of initial questionnaires and the patient can be on up to two prophylactic medications, with no changes during the 12 week period.